ARTICLE | Product Development
The first graduate of the institute’s preclinical stroke study is gearing up to enter its new clinical platform
By Selina Koch, Executive Editor
November 23, 2024 2:25 AM UTC
Every 3 minutes and 14 seconds, someone dies of stroke in the U.S., yet drug developers largely abandoned the indication years ago.
A string of clinical trial failures contributed to the retreat, which has led industry to virtually ignore the second-leading cause of death worldwide. It’s a massive unmet need that should be a major market opportunity. Factors behind the failures ranged from biological unknowns to poor preclinical animal models to the difficulties of executing human stroke trials…
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/654265/rescuing-stroke-drug-development-how-nih-is-leading-the-charge